Cuba's top biotech teams have successfully tested a new AIDS vaccine on mice, and are ready to soon begin human testing, a leading researcher told a biotechnology conference in Havana.
"The new AIDS trial vaccine already was tested successfully (on mice) and now we are preparing a very small, tightly controlled phase one clinical trial with HIV-positive patients who are not in the advanced stages of disease," researcher Enrique Iglesias said on Monday.
Iglesias, who heads up the vaccine development team at the Biotech and Genetic Engineering Center (CIGB) here, was speaking at the International Biotech Conference-Havana 2012, which started yesterday in Cuba's capital.
"The new AIDS trial vaccine already was tested successfully (on mice) and now we are preparing a very small, tightly controlled phase one clinical trial with HIV-positive patients who are not in the advanced stages of disease," researcher Enrique Iglesias said on Monday.
Iglesias, who heads up the vaccine development team at the Biotech and Genetic Engineering Center (CIGB) here, was speaking at the International Biotech Conference-Havana 2012, which started yesterday in Cuba's capital.